Joint research with VLP Therapeutics Japan and the Research Foundation for Microbial Diseases, Osaka University, on a next-generation mRNA influenza vaccine

An individual theme involving joint research with VLP Therapeutics Japan and the Research Foundation for Microbial Diseases, Osaka University, on an influenza vaccine using next-generation mRNA technology. The focus is on specific partners, mRNA technology and influenza vaccine development.